Here are relevant reports on : education-administration-market
-
North America Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The North America vaccines market, valued at US$25.95 billion in 2024, stood at US$25.29 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$35.68 billion by the end of the period. The vaccines market is growing rapidly, driven by swift global vaccine development and commercialization, higher rates of infectious diseases necessitating preventive vaccines, expanded immunization initiatives, innovations in vaccine technology, and increased government funding and investments for novel vaccines against diverse diseases.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030
The global injectable drug delivery market, valued at USD 633.77 billion in 2024, stood at USD 690.23 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of USD 1,034.78 billion by the end of the period. The injectable drug delivery market is driven by the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, alongside an increasing global demand for biologics.
- Published: May 2025
- Price: $ 8150
- TOC Available:
-
US General Anesthesia Drugs Market by Route of Administration (Intravenous and Inhalational), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast to 2025
The global US general anesthesia drugs market in terms of revenue was estimated to be worth $2.0 billion in 2020 and is poised to reach $2.4 billion by 2025, growing at a CAGR of 3.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Contrast Media Market By Type (lodinated Contrast Media), Form (Liquid, Powder), Modality (X-ray, MRI, Ultrasound), Route of Administration (Oral, Rectal), Indication (Cancer, Neurological, GI, Musculoskeletal Disorders) & Region - Global Forecast to 2031
The Contrast Media market, valued at USD 7.65 billion in 2025, stood at USD 8.20 billion in 2026 and is projected to advance at a resilient CAGR of 7.9% from 2026 to 2031, culminating in a forecasted valuation of USD 12.08 billion by the end of the period. Factors driving this growth include the increase in people with chronic conditions, like cardiovascular disease, cancer and neurological disorders, and, also, increase in the number of people getting diagnostic imaging tests on a global basis.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market By Administration Route (Oral, Injectable, Topical, Ocular, Nasal, Transmucosal & Implantable, Pulmonary, Transdermal Patch), Application (Cancer, Diabetes, Cardiovascular), Facility of Use - Global Forecast to 2031
The global pharmaceutical drug delivery market is projected to reach USD 2,922.82 billion by 2031, growing at a CAGR of 6.3% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Identity and Access Management (IAM) Market by Technology [Access Management, Identity Governance & Administration (IGA), Privileged Access Management (PAM)], Type (Workforce, CIAM, B2B), Identity Type, Deployment Mode, Vertical - Global Forecast to 2030
The identity and access management (IAM) market is expected to grow from USD 25.96 billion in 2025 to USD 42.61 billion by 2030, at a compound annual growth rate (CAGR) of 10.4% during the forecast period. The Key Players Microsoft (US), Ping Identity (US), IBM (US), Okta (US), Oracle (US), SailPoint (US), Saviynt (US), CyberArk (US), Thales (France), Akamai Technologies (US), OpenText (Canada), Entrust (US), Duo Security (US), HID Global (US), Evidian (France), RSA Security (US), Avatier (US), ManageEngine (US), SecureAuth (US), EmpowerID (US), Simeio (US), One Identity (US), FusionAuth (US), Auth0 (US), IDnow (Germany), Zuora (US), Signzy (India), Civic Technologies (US), Trusona (US), Beyond Identity (US), Delinea (US), Optimal IdM (US), Netwrix (US), Aquera (US), Cerby (US), Traxion (Netherlands), Radiant Logic (US), Elimity (Belgium), Oleria (US), Veza (US), Bravura Security (Canada), Fischer Identity (US), Lumos (US), Omada (Denmark), OpenIAM (US), Pathlock (US), Tuebora (US), and Rippling (US)
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Bovine, Ruminant, Canine, Feline, Aquaculture), Technology (Live Attenuated, Inactivated, Toxoid, Recombinant), Route of Administration (Subcutaneous, Oral), End User - Global Forecast to 2031
The global veterinary vaccines market is projected to reach USD 18.46 billion by 2031, growing at a CAGR of 7.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Europe Infusion Pump Market by Product [Accessories (Dedicated, Non-dedicated), Device (Insulin, Syringe, Volumetric, Enteral, PCA Pump)], Application (Chemotherapy, Diabetes, Analgesia), Mode of Administration (Subcutaneous, Epidural) - Forecast to 2031
The Europe infusion pump market, valued at USD 4.78 billion in 2025, stood at USD 5.10 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of USD 7.09 billion by the end of the period.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030
The global vaccines market (excluding COVID-19 vaccines), valued at USD 49.59 billion in 2024, stood at USD 47.65 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of USD 67.91 billion by the end of the period.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
